Therapeutic Substances Regulations (Amendment)

Overview

The Statutory Rules 1965 No. 60, enacted under the Therapeutic Substances Act 1953-1959, were introduced to address the need for a more structured and expert-driven evaluation process for therapeutic substances in Australia. The problem these regulations sought to address was the lack of a dedicated committee to perform comprehensive medical and scientific evaluations of therapeutic substances, ensuring their safety and efficacy before they were distributed within Australia. Enacted by the Administrator of the Government of the Commonwealth of Australia, acting on the advice of the Federal Executive Council, the regulations established the Australian Drug Evaluation Committee, comprised of eminent medical practitioners. This committee was tasked with evaluating therapeutic substances referred to it by the Minister, providing essential advice on the importation and distribution of these substances, thereby safeguarding public health.

Scope and Application

The Therapeutic Substances Regulations, made under the Therapeutic Substances Act 1953-1959, establish a framework for the regulation of therapeutic substances within Australia. These regulations apply to all therapeutic substances, which include medicines, and cover both the importation and distribution of such substances within Australia. The regulations are applicable across the entire Commonwealth, meaning they have a national reach. They mandate the creation of the Australian Drug Evaluation Committee, which is responsible for evaluating the medical and scientific merits of therapeutic substances referred to it by the Minister, as well as any substances the committee deems necessary to evaluate. This committee comprises seven members, including medical practitioners and pharmacologists, appointed by the Minister, with one member designated as the chairman. The committee's evaluations and advice are instrumental in guiding the Minister's decisions on the importation and distribution of therapeutic substances in Australia. The regulations also amend existing provisions to clarify the roles and responsibilities of the committee, ensuring that its evaluations and advice are integral to the regulatory process.

Key Provisions

The Therapeutic Substances Regulations of 1965 introduce new regulations under the Therapeutic Substances Act 1953-1959, with a focus on the establishment of the Australian Drug Evaluation Committee. Regulation 21a creates this committee, which is to consist of seven medical practitioners, with specific requirements for their expertise (21a(2)). The Minister is tasked with appointing the members of the Committee, including designating one member as the chairman (21a(3)-(4)). The primary functions of the Committee include evaluating therapeutic substances referred to them by the Minister, initiating evaluations of other substances deemed necessary, and providing the Minister with relevant advice on the importation and distribution of therapeutic substances within Australia (21a(5)). The obligations imposed by these regulations primarily concern the establishment and functioning of the Australian Drug Evaluation Committee. The Minister must ensure that the Committee is composed according to the specified qualifications and that it operates effectively to fulfill its mandated functions. This includes conducting thorough medical and scientific evaluations of therapeutic substances and offering expert advice on their regulation within Australia. The Committee must operate under the direction and oversight of the Minister, who retains the authority to appoint its members and chair. Failure to comply with the regulations may result in legal consequences. Although the specific penalties are not detailed within the provided text, breaches of regulations under the Therapeutic Substances Act could potentially lead to administrative sanctions, fines, or other legal actions. The precise penalties would depend on the nature and severity of the breach, as well as any relevant provisions within the broader Therapeutic Substances Act 1953-1959. The regulations underscore the importance of adherence to the established procedures for the evaluation and regulation of therapeutic substances to ensure public health and safety.